Business
Laekna Announces IND Approval of LAE120 (a Novel USP1 Inhibitor) for Treatment of Advanced Solid Tumors by FDA
LOS ANGELES, March 04, 2025--Laekna (2105.HK) announced that the U.S. Food and Drug Administration (FDA) has approved the IND for LAE120, an internally discovered USP1 inhibitor, for the treatment of advanced solid tumors.
About this update from Laekna, Inc.
[{"type":"image","alt":"Laekna (2105.HK) announced that the FDA has approved the IND for LAE120, an internally discovered USP1 inhibitor, for the treatment of advanced solid tumors. (Photo: Business Wire)","displaySize":"","headline":null,"caption":"Laekna (2105.HK) announced that the FDA has approved the IND for LAE120, an internally discovered USP1 inhibitor, for the treatment of advanced solid tumors. (Photo: Business Wire)","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":251,"url":"https://media.zenfs.com/en/business-wire.com/a9cc37273f3410a156c3988668199ff5"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/MQgpXxPnWonZYURXcVBLBw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTUwMjtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/a9cc37273f3410a156c3988668199ff5","width":480,"height":251}},"lazy":false},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":2340,"height":751,"url":"https://media.zenfs.com/en/business-wire.com/a732618b7586ac356049e9ed4ed730d8"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/R9le.rE1Qby_pO1AYtn0AA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTMwODtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/a732618b7586ac356049e9ed4ed730d8","width":960,"height":308},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/u57Oi2ZO.cAqPnMKEnTydw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD03NzA7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/a732618b7586ac356049e9ed4ed730d8","width":1200,"height":385}}},{"type":"list","items":[{"val":[{"type":"text","content":"A novel, allosteric and highly potent USP1 inhibitor, LAE120 exhibits robust tumor inhibitory activity across various xenograft models","length":134,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Significantly accelerated the progress of drug discovery leveraging cutting-edge AI models","length":90,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Another potential anti-tumor drug candidate, LAE118 (a mutant-selective PI3Kα inhibitor) also in IND-enabling studies","length":117,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":341,"olType":false},{"type":"text","content":"LOS ANGELES, March 04, 2025--(BUSINESS WIRE)--Laekna (2105.HK) announced that the U.S. Food and Drug Admini...